중남미 바이오 분석 시험 서비스 시장 시장 : 지역 분석 - 서비스별, 질환 적응증별, 최종 사용자별 예측(-2030년)

The South & Central America bioanalytical testing services market was valued at US$ 242.43 million in 2022 and is expected to reach US$ 491.76 million by 2030; it is estimated to grow at a CAGR of 9.2% from 2022 to 2030.

Uninterrupted Growth of Pharmaceuticals Industry Fuel the South & Central America Bioanalytical Testing Services Market

The research & development, production, and distribution of medicinal drugs and other pharmaceutical products are the major areas of the pharmaceutical industry. Global pharmaceutical consumption is rising with the increasing need for drugs to treat age-related diseases and chronic diseases. According to the WHO, the elderly population aged 60 or above is projected to double from 2020 to 2050, reaching ~2.1 billion by 2050. A rise in the geriatric population would contribute to a surge in incidences of chronic diseases, such as cardiovascular diseases, cancer, hypertension, osteoarthritis, and diabetes mellitus. Thus, chronic diseases have been a major area of focus for pharmaceutical companies. New drug development is a resource-, cost-, and time-intensive process, where later clinical stages result in significant costs. Several pharmaceutical companies are opting for bioanalytical testing services for drug development and validation of assays in both clinical and preclinical stages. Generics and branded drug compounds are mostly small molecules. Generics manufacturers conduct and submit bioanalytical testing results to overcome the issue of patent expiration. Thus, with the uninterrupted proliferation of the pharmaceutical industry, bioanalytical testing service providers are likely to experience a continuous rise in demand for their services in the future, which would lead to new growth opportunity in the bioanalytical testing services market.

South & Central America Bioanalytical Testing Services Market Overview

The bioanalytical testing services market in South & Central America is sub segmented into Brazil, Argentina, and the Rest of South & Central America. The market growth in this region is primarily attributed to the ongoing efforts of global pharmaceutical companies to establish their presence in the region, along with the increasing awareness about diseases and rising healthcare expenditure by countries.

South & Central America Bioanalytical Testing Services Market Revenue and Forecast to 2030 (US$ Million)

South & Central America Bioanalytical Testing Services Market Segmentation

The South & Central America bioanalytical testing services market is segmented based on test type, disease indication, end user, and country.

Based on test type, the South & Central America bioanalytical testing services market is segmented into pharmacokinetics, biomarkers, immunogenicity, virology testing, cell-based assays, and others. The cell-based assays segment held the largest market share in 2022.

Based on disease indication, the South & Central America bioanalytical testing services market is segmented into cardiovascular, neurological disorders, metabolic disorders, respiratory diseases, autoimmune disorder, oncology, sexual health, bone disease, and others. The oncology segment held the largest market share in 2022.

Based on end user, the South & Central America bioanalytical testing services market is segmented into pharmaceutical and biopharmaceutical companies, contract research organization (CRO), contract development and manufacturing organization (CDMO), and others. The pharmaceutical and biopharmaceutical companies segment held the largest market share in 2022.

Based on country, the South & Central America bioanalytical testing services market is segmented into Brazil, Argentina, and the Rest of South & Central America. Brazil dominated the South & Central America bioanalytical testing services market share in 2022.

SGS SA, Pharmaron Beijing Co Ltd, Element Materials Technology Group Ltd, Charles River Laboratories International Inc, Eurofins Scientific SE, Labcorp Drug Development Inc, Syneos Health Inc, ICON Plc, and Intertek Group Plc are some of the leading companies operating in the South & Central America bioanalytical testing services market.

Table Of Contents

Table of Content

1. Introduction

• 1.1 The Insight Partners Research Report Guidance
• 1.2 Market Segmentation

2. Executive Summary

• 2.1 Key Insights

3. Research Methodology

• 3.1 Coverage
• 3.2 Secondary Research
• 3.3 Primary Research

4. South & Central America Bioanalytical Testing Services Market Landscape

• 4.1 Overview
• 4.2 PEST Analysis
  • 4.2.1 South & Central America PEST Analysis

5. South & Central America Bioanalytical Testing Services Market - Key Industry Dynamics

• 5.1 Key Market Drivers:
  • 5.1.1 Increasing Outsourcing of R&D Activities by Pharmaceutical Companies
  • 5.1.2 High Demand for Analytical Testing of Biosimilars and Biologics
• 5.2 Key Market Restraints:
  • 5.2.1 High Cost Associated to Bioanalytical Testing Services
• 5.3 Key Market Opportunities
  • 5.3.1 Uninterrupted Growth of Pharmaceuticals Industry
• 5.4 Future Trends
  • 5.4.1 Rising Drug Discovery and Development Activities for Emerging and Rare Diseases
• 5.5 Impact Analysis:

6. Bioanalytical Testing Services Market - South & Central America Market Analysis

• 6.1 Bioanalytical Testing Services Market Revenue (US$ Mn), 2022 - 2030

7. South & Central America Bioanalytical Testing Services Market - Revenue and Forecast to 2030 - by Services

• 7.1 Overview
• 7.2 Bioanalytical Testing Services Market Revenue Share, by Services 2022 & 2030 (%)
• 7.3 Pharmacokinetics
  • 7.3.1 Overview
  • 7.3.2 Pharmacokinetics: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
• 7.4 Biomarkers
  • 7.4.1 Overview
  • 7.4.2 Biomarkers: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
• 7.5 Immunogenicity
  • 7.5.1 Overview
  • 7.5.2 Immunogenicity: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
• 7.6 Virology Testing
  • 7.6.1 Overview
  • 7.6.2 Virology Testing: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
    • 7.6.2.1 In-Vitro Virology Testing
      • 7.6.2.1.1 Overview
    • 7.6.2.2 In-Vitro Virology Testing: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.6.3 In-Vivo Virology Testing
    • 7.6.3.1 Overview
    • 7.6.3.2 In-Vivo Virology Testing: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
• 7.7 Cell-Based Assays
  • 7.7.1 Overview
  • 7.7.2 Cell-Based Assays: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
• 7.8 Others
  • 7.8.1 Overview
  • 7.8.2 Others: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)

8. South & Central America Bioanalytical Testing Services Market - Revenue and Forecast to 2030 - by Disease Indication

• 8.1 Overview
• 8.2 Bioanalytical Testing Services Market Revenue Share, by Disease Indication 2022 & 2030 (%)
• 8.3 Cardiovascular
  • 8.3.1 Overview
  • 8.3.2 Cardiovascular: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
• 8.4 Neurological Diseases
  • 8.4.1 Overview
  • 8.4.2 Neurological Diseases: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
• 8.5 Metabolic Disorders
  • 8.5.1 Overview
  • 8.5.2 Metabolic Disorders: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
• 8.6 Oncology
  • 8.6.1 Overview
  • 8.6.2 Oncology: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
• 8.7 Sexual Health
  • 8.7.1 Overview
  • 8.7.2 Sexual Health: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
• 8.8 Bone Disease
  • 8.8.1 Overview
  • 8.8.2 Bone Disease: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
• 8.9 Others
  • 8.9.1 Overview
  • 8.9.2 Others: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)

9. South & Central America Bioanalytical Testing Services Market - Revenue and Forecast to 2030 - by End User

• 9.1 Overview
• 9.2 Bioanalytical Testing Services Market Revenue Share, by End User 2022 & 2030 (%)
• 9.3 Pharmaceutical and Biopharmaceutical Companies
  • 9.3.1 Overview
  • 9.3.2 Pharmaceutical and Biopharmaceutical Companies: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
• 9.4 Contract Research Organization (CRO)
  • 9.4.1 Overview
  • 9.4.2 Contract Research Organization (CRO): Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
• 9.5 Contract Development and Manufacturing Organization (CDMO)
  • 9.5.1 Overview
  • 9.5.2 Contract Development and Manufacturing Organization (CDMO): Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
• 9.6 Others
  • 9.6.1 Overview
  • 9.6.2 Others: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)

10. South & Central America Bioanalytical Testing Services Market - Country Analysis

• 10.1 South & Central America Bioanalytical Testing Services Market, Revenue and Forecast to 2030
  • 10.1.1 Overview
    • 10.1.1.1 South & Central America Bioanalytical Testing Services Market by Country
    • 10.1.1.2 Brazil
      • 10.1.1.2.1 Overview
      • 10.1.1.2.2 Brazil Bioanalytical Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
      • 10.1.1.2.3 Brazil Bioanalytical Testing Services Market, by Services
      • 10.1.1.2.3.1 Brazil Bioanalytical Testing Services Market, by Virology Testing
      • 10.1.1.2.4 Brazil Bioanalytical Testing Services Market, by Disease Indication
      • 10.1.1.2.5 Brazil Bioanalytical Testing Services Market, by End User
    • 10.1.1.3 Argentina
      • 10.1.1.3.1 Overview
      • 10.1.1.3.2 Argentina Bioanalytical Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
      • 10.1.1.3.3 Argentina Bioanalytical Testing Services Market, by Services
      • 10.1.1.3.3.1 Argentina Bioanalytical Testing Services Market, by Virology Testing
      • 10.1.1.3.4 Argentina Bioanalytical Testing Services Market, by Disease Indication
      • 10.1.1.3.5 Argentina Bioanalytical Testing Services Market, by End User
    • 10.1.1.4 Rest of South & Central America
      • 10.1.1.4.1 Overview
      • 10.1.1.4.2 Rest of South & Central America Bioanalytical Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
      • 10.1.1.4.3 Rest of South & Central America Bioanalytical Testing Services Market, by Services
      • 10.1.1.4.3.1 Rest of South & Central America Bioanalytical Testing Services Market, by Virology Testing
      • 10.1.1.4.4 Rest of South & Central America Bioanalytical Testing Services Market, by Disease Indication
      • 10.1.1.4.5 Rest of South & Central America Bioanalytical Testing Services Market, by End User

11. Bioanalytical Testing Services Market Industry Landscape

• 11.1 Overview
• 11.2 Growth Strategies in the Bioanalytical Testing Services Market
• 11.3 Inorganic Growth Strategies
  • 11.3.1 Overview
• 11.4 Organic Growth Strategies
  • 11.4.1 Overview

12. Company Profiles

• 12.1 SGS SA
  • 12.1.1 Key Facts
  • 12.1.2 Business Description
  • 12.1.3 Products and Services
  • 12.1.4 Financial Overview
  • 12.1.5 SWOT Analysis
  • 12.1.6 Key Developments
• 12.2 Pharmaron Beijing Co Ltd
  • 12.2.1 Key Facts
  • 12.2.2 Business Description
  • 12.2.3 Products and Services
  • 12.2.4 Financial Overview
  • 12.2.5 SWOT Analysis
  • 12.2.6 Key Developments
• 12.3 Element Materials Technology Group Ltd
  • 12.3.1 Key Facts
  • 12.3.2 Business Description
  • 12.3.3 Products and Services
  • 12.3.4 Financial Overview
  • 12.3.5 SWOT Analysis
  • 12.3.6 Key Developments
• 12.4 Charles River Laboratories International Inc
  • 12.4.1 Key Facts
  • 12.4.2 Business Description
  • 12.4.3 Products and Services
  • 12.4.4 Financial Overview
  • 12.4.5 SWOT Analysis
  • 12.4.6 Key Developments
• 12.5 Eurofins Scientific SE
  • 12.5.1 Key Facts
  • 12.5.2 Business Description
  • 12.5.3 Products and Services
  • 12.5.4 Financial Overview
  • 12.5.5 SWOT Analysis
  • 12.5.6 Key Developments
• 12.6 Labcorp Drug Development Inc
  • 12.6.1 Key Facts
  • 12.6.2 Business Description
  • 12.6.3 Products and Services
  • 12.6.4 Financial Overview
  • 12.6.5 SWOT Analysis
  • 12.6.6 Key Developments
• 12.7 Syneos Health Inc
  • 12.7.1 Key Facts
  • 12.7.2 Business Description
  • 12.7.3 Products and Services
  • 12.7.4 Financial Overview
  • 12.7.5 SWOT Analysis
  • 12.7.6 Key Developments
• 12.8 ICON Plc
  • 12.8.1 Key Facts
  • 12.8.2 Business Description
  • 12.8.3 Products and Services
  • 12.8.4 Financial Overview
  • 12.8.5 SWOT Analysis
  • 12.8.6 Key Developments
• 12.9 Intertek Group Plc
  • 12.9.1 Key Facts
  • 12.9.2 Business Description
  • 12.9.3 Products and Services
  • 12.9.4 Financial Overview
  • 12.9.5 SWOT Analysis
  • 12.9.6 Key Developments

13. Appendix

• 13.1 About Us
• 13.2 Glossary of Terms